Quality of asthma care: Results from a community pharmacy based survey

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 60, Issue 12, 2005, Pages 1505-1510

  Laforest, L ^a   Van Ganse, Eric ^a,c   Devouassoux, G ^a   Chretin, S ^a   Bauguil, G ^b   Pacheco, Y ^a   Chamba, G ^b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

Asthma; Epidemiology; Prevention

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; XANTHINE;

ADULT; ARTICLE; ASTHMA; AUTOMATION; CONTROLLED STUDY; DISEASE CONTROL; DYSPNEA; FEMALE; GENERAL PRACTITIONER; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NOCTURNAL ASTHMA; PHARMACY; PRIORITY JOURNAL; QUESTIONNAIRE; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; ANTI-ASTHMATIC AGENTS; ASTHMA; DELIVERY OF HEALTH CARE; FEMALE; FRANCE; HEALTH CARE SURVEYS; HUMANS; MALE; MIDDLE AGED; PHARMACIES; QUESTIONNAIRES;

EID: 27844475675     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2005.00923.x     Document Type: Article

References (20)

1. de Marco R, Bugiani M, Cazzoletti L, Carosso A, Accordini S, Buriani O et al. ISAYA study group. The control of asthma in Italy. A multicentre descriptive study on young adults with doctor diagnosed current asthma. Allergy 2003;58:221-228.
2. Van Ganse E, Boissel JP, Gormand F, Ernst P. Level of control and hospital contacts in persistent asthma. J Asthma 2001;38:637-643.
3. Krishnan JA, Riekert KA, McCoy JV, Stewart DY, Schmidt S, Chanmugam A et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004;170:1281-1285.
4. Jowers JR, Schwartz AL, Tinkelman DG, Reed KE, Corsello PR, Mazzei AA et al. Disease management program improves asthma outcomes. Am J Manag Care 2000;6:585-592.
5. Nathan RA, Sorkness CA, Kosinski M, Schatz M, Li JT, Marcus P et al. Development of the asthma control test: a survey for assessing asthma control. J Allergy Clin Immunol 2004;113:59-65.
6. Rabe KF, Adachi M, Lai CK, Soriano JB, Vermeire PA, Weiss KB et al. Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004;114:40-47.
7. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NHLBI/WHO WORKSHOP Report (updated 2002). Bestheda, MD, USA: National Institute of Health, 2002.
8. Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000;105:1108-1116.
9. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. GOAL Investigators Group. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study. Am J Respir Crit Care Med 2004;170:836-844.
10. Mann M, Chowdhury B, Sullivan E, Nicklas R, Anthracite R, Meyer RJ. Serious asthma exacerbations in asthmatics treated with high-dose formoterol. Chest 2003;124:70-74.
11. Van Ganse E, Mork AC, Osman LM, Vermeire P, Laforest L, Marrel A et al. Factors affecting adherence to asthma treatment: patient and physician perspectives. Prim Care Resp J 2003;12:46-51.
12. Boulet LP, Belanger M, Lajoie P. Characteristics of subjects with a high frequency of emergency visits for asthma. Am J Emerg Med 1996;14:623-628.
13. Cote J, Cartier A, Robichaud P, Boutin H, Malo JL, Rouleau M et al. Influence on asthma morbidity of asthma education programs based on self-management plans following treatment optimization. Am J Respir Crit Care Med 1997;155:1509-1514.
14. Melani AS, Zanchetta D, Barbato N, Sestini P, Cinti C, Canessa PA et al. Inhalation technique and variables associated with misuse of conventional metered-dose inhalers and newer dry powder inhalers in experienced adults. Ann Allergy Asthma Immunol 2004;93:439-446.
15. Marks GB, Jalaludin BB, Williamson M, Atkin NL, Bauman A. Use of "preventer" medications and written asthma management plans among adults with asthma in New South Wales. NSW Health Department Asthma Data Working Group. Med J Aust 2000;173:407-410.
16. Delaney B. Updating guidelines on asthma in adults. BMJ 2001;323:1380-1381.
17. Demoly P, Crestani B, Leroyer C, Magnan A, Mounedji N, Humbert M. Control and exacerbation of asthma: a survey of more than 3000 French physicians. Allergy 2004;59:920-926.
18. Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 2003;28:395-402.
19. Saini B, Krass I, Armour C. Development, implementation, and evaluation of a community pharmacy-based asthma care model. Ann Pharmacother 2004;38:1954-1960.
20. Members of the Workshops. ARIA in the pharmacy: management of allergic rhinitis symptoms in the pharmacy. Allergic rhinitis and its impact on asthma. Allergy 2004;59:373-387.